Shimadzu Corporation has invested in Rhinoflux Inc., a company pioneering carbon dioxide capture and biomass energy technologies, through its Shimadzu Future Innovation Fund (FIF). This investment ...

Dental support organisation Benevis is revolutionising patient care by implementing an assisted hygiene delivery model. Designed to improve both efficiency and patient experience, this model aims to ...

In a strategic financial move, Acadia Pharmaceuticals has successfully sold a pediatric review voucher (PRV) for $150 million, resulting in a substantial $100 million profit. This transaction ...

Biosynth, a global supplier of critical raw materials and services to the life sciences industry, today announced that its Board of Directors has appointed Matt Gunnison as the company’s new Chief ...

Lintbells, a renowned pet supplement manufacturer, has issued a warning to consumers about counterfeit versions of their celebrated products surfacing in the market. This situation poses significant ...

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the third quarter ended ...

The Agriculture and Horticulture Development Board has issued a vital alert to UK cattle farmers regarding a growing risk of lungworm infections. Due to prevailing weather conditions, the potential ...

Novo Nordisk today announced the headline results from part 1 of the ongoing ESSENCE trial, a pivotal phase 3, 240-week, double-blinded trial in 1,200 adults with metabolic dysfunction-associated ...

Switzerland-based FKG Dentaire, a leader in dental equipment manufacturing, has expanded its market presence to the UK. This move is poised to bring advanced dental solutions to British dental ...

Agfa HealthCare has announced a pivotal collaboration with St Jansdal Hospital to deploy cutting-edge imaging solutions. This significant move aims to enhance both the quality and efficiency of ...

H. Lundbeck A/S (Lundbeck) announced that Vyepti® (eptinezumab) met the primary and all key secondary endpoints in SUNRISE, a phase III pivotal clinical trial predominantly conducted in Asia ...

The University of Liverpool has been awarded a significant £1 million in funding to enhance its equine research efforts. This substantial financial support aims to bolster the university’s capacity to ...